Publication: Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia
| dc.contributor.author | García Carmona, Juan Antonio | |
| dc.contributor.author | Amores Iniesta, Joaquín | |
| dc.contributor.author | Soler Usero, José | |
| dc.contributor.author | Cerdán Sánchez, María | |
| dc.contributor.author | Navarro Zaragoza, Javier | |
| dc.contributor.author | López López, María | |
| dc.contributor.author | Soria Torrecillas, Juan José | |
| dc.contributor.author | Ballesteros Arenas, Ainhoa | |
| dc.contributor.author | Pérez Vicente, José Antonio | |
| dc.contributor.author | Almela Rojo, Pilar | |
| dc.contributor.department | Farmacología | |
| dc.date.accessioned | 2026-03-27T11:46:04Z | |
| dc.date.available | 2026-03-27T11:46:04Z | |
| dc.date.issued | 2023-06-23 | |
| dc.description.abstract | We report a 49-year-old patient suffering from spastic paraplegia with a novel heterozygous mutation and analyzed the levels of heat shock proteins (hsp)-27, dopamine (DA), and its metabolites in their cerebrospinal fluid (CSF). The hsp27 protein concentration in the patient’s CSF was assayed by an ELISA kit, while DA levels and its metabolites in the CSF, 3,4-dihydroxyphenylacetic acid (DOPAC), Cys-DA, and Cys-DOPA were measured by HPLC. Whole exome sequencing demonstrated SPG-11 c.1951C>T and novel SYNJ1 c.2614G>T mutations, both heterozygous recessive. The patient’s DA and DOPAC levels in their CSF were significantly decreased (53.0 6.92 and 473.3 72.19, p < 0.05, respectively) while no differences were found in their Cys-DA. Nonetheless, Cys-DA/DOPAC ratio (0.213 0.024, p < 0.05) and hsp27 levels (1073.0 136.4, p < 0.05) were significantly higher. To the best of our knowledge, the c.2614G>T SYNJ1 mutation has not been previously reported. Our patient does not produce fully functional spatacsin and synaptojanin-1 proteins. In this line, our results showed decreased DA and DOPAC levels in the patient’s CSF, indicating loss of DAergic neurons. Many factors have been described as being responsible for the increased cys-DA/DOPAC ratio, such as MAO inhibition and decreased antioxidant activity in DAergic neurons which would increase catecholquinones and consequently cysteinyl-catechols. In conclusion, haploinsufficiency of spatacsin and synaptojanin-1 proteins might be the underlying cause of neurodegeneration produced by protein trafficking defects, DA vesicle trafficking/recycling processes, autophagy dysfunction, and cell death leading to hsp27 upregulation as a cellular mechanism of protection and/or to balance impaired protein trafficking. | |
| dc.format | application/pdf | |
| dc.format.extent | 10 | |
| dc.identifier.citation | García-Carmona, J.A.; Amores-Iniesta, J.; Soler-Usero, J.; Cerdán-Sánchez, M.; Navarro-Zaragoza, J.; López-López, M.; Soria-Torrecillas, J.J.; Ballesteros-Arenas, A.; Pérez-Vicente, J.A.; Almela, P. Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia. Genes 2023, 14, 1320. https://doi.org/10.3390/ genes14071320 | |
| dc.identifier.doi | doi.org/10.3390/genes14071320 | |
| dc.identifier.issn | 2073-4425 | |
| dc.identifier.uri | http://hdl.handle.net/10201/223661 | |
| dc.language | eng | |
| dc.relation | This study was supported by the Servicio Murciano de Salud, (Spain); the Spanish Ministry of Science ref: SAF/FEDER2017-83855-R and ref: PID2020-103611; and the Seneca Foundation: Science and Technology Agency of the Region of Murcia (Spain) ref: 20847/PI/18. | |
| dc.relation.publisherversion | https://www.mdpi.com/2073-4425/14/7/1320 | |
| dc.rights | Attribution 4.0 International | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Spatacsin | |
| dc.subject | Synaptojanin | |
| dc.subject | Heat-shock protein 27 | |
| dc.subject | Dopamine oxidation | |
| dc.subject | Spastic paraplegia | |
| dc.subject.ods | Objetivo 3: Salud | |
| dc.title | Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dspace.entity.type | Publication | es |
| relation.isAuthorOfPublication | ed1a6db8-9052-4cc4-977c-4e32e92bc6e4 | |
| relation.isAuthorOfPublication | 91a9c0cf-0115-4c34-9b53-72a417c2d883 | |
| relation.isAuthorOfPublication | 5028b798-617b-4311-8389-11b8f71ac210 | |
| relation.isAuthorOfPublication.latestForDiscovery | ed1a6db8-9052-4cc4-977c-4e32e92bc6e4 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 Mutations Causing Clinical Spastic Paraplegia.pdf
- Size:
- 2.34 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.37 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
Collections
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by/4.0/